1-4 of 4
Yunju Ma
Close
Sort by
Journal Articles

Chidamide Combined with a Modified Bu-Cy Conditioning Regimen Improves Survival in Patients with T-Cell Acute Lymphoblastic Leukemia/Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Xuanqi Cao, Zheng Li, Yanming Zhang, Qingya Cui, Yunju Ma, Mengyun Li, Sifan Chen, Jia Yin, Wei Cui, Jia Chen, Aining Sun, Huiying Qiu, Suning Chen, Zhengming Jin, Xiaming Zhu, De-Pei Wu, Xiaowen Tang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6959.
https://doi.org/10.1182/blood-2023-185258
Published: 2023
Journal Articles

Decitabine in Combination with Fludarabine and Cyclophosphamide As Lymphodepletion Regimen Followed By CD19/CD22 Bispecific Targeted CAR-T Therapy Significantly Improves Survival in Relapsed/Refractory B-ALL Patients: A Pilot Study

Yunju Ma, Changju Qu, Haiping Dai, Sining Liu, Qingya Cui, Wei Cui, Jia Yin, Liqing Kang, Xiaying Lian, Huiying Qiu, Xiaming Zhu, Lei Yu, Depei Wu, Xiaowen Tang
Journal: Blood
Blood (2021) 138 (Supplement 1): 1754.
https://doi.org/10.1182/blood-2021-152041
Published: 2021
Journal Articles

Decitabine As Part of a Modified Bu-Cy Conditioning Regimen Significantly Improved the Outcome of High-Risk AML Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Xiaowen Tang, Benigno C. Valdez, PhD, Qianqian Zhang, Yunju Ma, Haiping Dai, Jia Yin, Zheng Li, Ting Xu, Yang Xu, MD PhD, Jia Chen, Xiaming Zhu, Depei Wu, MD PhD, Borje S Andersson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3270.
https://doi.org/10.1182/blood-2019-123951
Published: 2019
Journal Articles

Maintenance Therapy with Decitabine after Allogeneic Hematopoietic Stem Cell Transplantation to Prevent Relapse of High Risk Acute Myeloid Leukemia

Yunju Ma, Changju Qu, PhD, Haiping Dai, Jia Yin, Zheng Li, Jia Chen, Huiying Qiu, Aining Sun, PhD, Miao Miao, Chengcheng Fu, Zhengming Jin, MD, Xiaming Zhu, Depei Wu, MD PhD, Xiaowen Tang
Journal: Blood
Blood (2019) 134 (Supplement_1): 3306.
https://doi.org/10.1182/blood-2019-124033
Published: 2019